Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
82%
Importance
85%
Tractability
78%
Market price
50%

Description

The study shows PRKN specifically accelerates RHOT1 turnover, disrupting mitochondrial transport, but doesn’t explain why RHOT1 is preferentially targeted. Understanding this selectivity mechanism is crucial for developing targeted interventions that preserve mitochondrial transport while maintaining quality control.

Gap type: unexplained_observation Source paper: Broad activation of the PRKN pathway triggers synaptic failure by disrupting synaptic mitochondrial supply in early tauopathy. (None, None, PMID:35188059)